文献速递生殖医学

使用孕激素在卵巢刺激期间抑制自发排卵:新时代的开始?

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?
PubMed 文献 · Reprod Biomed Online · 2019-03-29

本综述总结了在卵巢刺激期间使用孕激素抑制排卵的现状,并与传统卵巢刺激进行比较。孕激素启动的卵巢刺激能有效抑制自发排卵,不影响获卵数和胚胎质量,生殖结局似乎与传统方案相似,但需大型试验确认。该方案可更好地控制LH浓度、降低成本且口服给药更方便。

要点

  • 孕激素启动的卵巢刺激能有效抑制自发排卵,不影响获卵数和胚胎质量。
  • 生殖结局似乎与传统卵巢刺激相似,但需大型试验确认。
  • 该方案可更好地控制LH浓度、降低成本且口服给药更方便。

核心结论

  • 孕激素启动的卵巢刺激可成为生育力保存、卵子捐赠和胚胎植入前遗传学检测周期的首选卵巢刺激方案。
  • 所谓的「非常规」卵巢刺激方案(黄体期和随机启动、双卵巢刺激)也可能使用孕激素抑制内源性LH峰。
  • 由于「全胚冷冻」策略延迟移植是强制性的,高反应者接受IVF可能从该方法中获益更多。
  • 经济优势以及妊娠和新生儿结局仍有待证实。

研究设计与样本

  • 本综述总结了在卵巢刺激期间使用孕激素抑制排卵的现状,并与传统卵巢刺激进行比较。

主要发现

  • 孕激素启动的卵巢刺激能有效抑制自发排卵,不影响获卵数和胚胎质量。
  • 孕激素卵巢刺激的生殖结局似乎与传统卵巢刺激相似,尽管需要大型试验来确认。
  • 使用孕激素可以更好地控制LH浓度、降低成本且(口服)给药更方便。

临床怎么用

  • 孕激素启动的卵巢刺激可成为生育力保存、卵子捐赠和胚胎植入前遗传学检测周期的首选卵巢刺激方案。
  • 所谓的「非常规」卵巢刺激方案(黄体期和随机启动、双卵巢刺激)也可能使用孕激素抑制内源性LH峰。
  • 由于「全胚冷冻」策略延迟移植是强制性的,高反应者接受IVF可能从该方法中获益更多。

局限性

  • 需要大型试验来确认生殖结局与传统卵巢刺激相似。
  • 经济优势仍有待证实。
  • 妊娠和新生儿结局仍有待证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Advances in oocyte and embryo cryopreservation for assisted reproduction prompted new approaches to ovarian stimulation. Attention has been paid to progesterone and its derivatives to block the LH surge, as oocyte vitrification removes possible harmful effects of progestins on endometrial receptivity. This review summarizes the current status of progestin use to inhibit ovulation during ovarian stimulation compared with conventional ovarian stimulation. Progestin-primed ovarian stimulation is shown to effectively inhibit spontaneous ovulation, without affecting the number of retrieved oocytes and embryo quality. Reproductive outcomes from ovarian stimulation with progestins appear similar to those from conventional ovarian stimulation, although large trials are needed to confirm this. Use of progestins allows better control of LH concentrations, lower costs and easier (oral) administration. Therefore, progestin-primed ovarian stimulation could be the first choice for ovarian stimulation in fertility preservation, oocyte donation and preimplantation genetic testing cycles. So-called 'non-conventional' ovarian stimulation protocols (luteal and random-start, double ovarian stimulation), which always require oocyte or embryo cryopreservation, may also use progestins to inhibit the endogenous LH surge. Since the 'freeze-all' strategy with delayed transfer is mandatory, high responders undergoing IVF could benefit more from this approach. Economic advantage remains to be demonstrated, as do pregnancy and neonatal outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. La Marca A, Capuzzo M. Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Reprod Biomed Online. 2019. PMID: 31138494. doi:10.1016/j.rbmo.2019.03.212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。